Preparation of multivesicular liposomes for the loco-regional delivery of Vancomycin hydrochloride using active loading method: drug release and antimicrobial properties

References

• Abdelkader, H., et al., 2011. Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. Journal of Pharmaceutical Sciences, 100 (5), 1833–1846.
   PubMed Web of Science ®Google Scholar
• Alavi, S., et al., 2021. Multivesicular liposomal depot system for sustained delivery of risperidone: development, characterization, and toxicity assessment. Drug Development and Industrial Pharmacy, 47 (8), 1290–1301.
   PubMed Web of Science ®Google Scholar
• Ambrose, C.G., et al., 2004. Effective treatment of osteomyelitis with biodegradable microspheres in a rabbit model. Clinical Orthopaedics & Related Research, 421, 293–299.
   Web of Science ®Google Scholar
• Bauer, A.W., PERRY, D.M., and KIRBY, W.M., 1959. Single-disk antibiotic-sensitivity testing of staphylococci: an analysis of technique and results. A.M.A. archives of Internal Medicine, 104 (2), 208–216.
   PubMedGoogle Scholar
• Bolotin, E.M., et al. 1994. Ammonium sulfate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandoliposomes. Journal of Liposome Research, 4 (1), 455–479.
   Google Scholar
• Chen, Z., et al. 2018. Encapsulation of green tea polyphenol by pH responsive, antibacterial, alginate microgels used for minimally invasive treatment of bone infection. Colloids and Surfaces. B, Biointerfaces, 170, 648–655.
   PubMed Web of Science ®Google Scholar
• Chen, Z., et al. 2018. Construction of injectable, pH sensitive, antibacterial, mineralized amino acid yolk-shell microspheres for potential minimally invasive treatment of bone infection. International Journal of Nanomedicine, 13, 3493–3506.
   PubMed Web of Science ®Google Scholar
• Chung, M.F., et al. 2014. Inflammation‐induced drug release by using a pH‐responsive gas‐generating hollow‐microsphere system for the treatment of osteomyelitis. Advanced Healthcare Materials, 3 (11), 1854–1861.
   PubMed Web of Science ®Google Scholar
• Deshantri, A.K., et al. 2019. Development and characterization of liposomal formulation of bortezomib. International Journal of Pharmaceutics: X, 1, 100011.
   PubMedGoogle Scholar
• Ferreira, I.S., et al. 2015. Activity of daptomycin-and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms. International Journal of Nanomedicine, 10, 4351–4366.
   PubMed Web of Science ®Google Scholar
• Ford, C.A., and Cassat, J.E., 2017. Advances in the local and targeted delivery of anti-infective agents for management of osteomyelitis. Expert Review of anti-Infective Therapy, 15 (9), 851–860.
   PubMed Web of Science ®Google Scholar
• Gogia, J.S., et al. 2009. Local antibiotic therapy in osteomyelitis. Seminars in Plastic Surgery, 23 (2), 100–107. In (Vol. No.© Thieme Medical Publishers.
   PubMedGoogle Scholar
• Gomes, D., Pereira, M., and Bettencourt, A.F., 2013. Osteomyelitis: an overview of antimicrobial therapy. Brazilian Journal of Pharmaceutical Sciences, 49 (1), 13–27.
   Web of Science ®Google Scholar
• Grant, G.J., et al. 2004. A novel liposomal bupivacaine formulation to produce ultralong-acting analgesia. Anesthesiology, 101 (1), 133–137.
   PubMed Web of Science ®Google Scholar
• Gubernator, J., 2011. Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity. Expert Opinion on Drug Delivery, 8 (5), 565–580.
   PubMed Web of Science ®Google Scholar
• Hajiahmadi, F., et al. 2019. The bactericidal effect of liposomal vancomycin as a topical combating system against Methicillin-resistant Staphylococcus aureus skin wound infection in mice. Medical Journal of the Islamic Republic of Iran, 33, 153.
   PubMedGoogle Scholar
• Haran, G., et al. 1993. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochimica et Biophysica Acta, 1151 (2), 201–215.
   PubMed Web of Science ®Google Scholar
• Hassani Besheli, N., et al. 2017. Sustainable release of vancomycin from silk fibroin nanoparticles for treating severe bone infection in rat tibia osteomyelitis model. ACS Applied Materials & Interfaces, 9 (6), 5128–5138.
   PubMed Web of Science ®Google Scholar
• Inzana, J.A., et al. 2016. Biomaterials approaches to treating implant-associated osteomyelitis. Biomaterials, 81, 58–71.
   PubMed Web of Science ®Google Scholar
• Jain, S.K., et al. 2007. Multivesicular liposomes bearing celecoxib-β-cyclodextrin complex for transdermal delivery. Drug Delivery, 14 (6), 327–335.
   PubMed Web of Science ®Google Scholar
• Hall, J. S., et al. 2022. Manufacturing of bupivacaine multivesicular liposomes. United States Patent Application US11033495B1, 28 July
   Google Scholar
• Jung, S.W., et al. 2019. In situ gelling hydrogel with anti-bacterial activity and bone healing property for treatment of osteomyelitis. Tissue Engineering and Regenerative Medicine, 16 (5), 479–490.
   PubMed Web of Science ®Google Scholar
• Kadry, A.A., et al. 2004. Treatment of experimental osteomyelitis by liposomal antibiotics. The Journal of Antimicrobial Chemotherapy, 54 (6), 1103–1108.
   PubMed Web of Science ®Google Scholar
• Kankilic, B., et al. 2011. Vancomycin containing PLLA/β-TCP controls MRSA in vitro. Clinical Orthopaedics and Related Research, 469 (11), 3222–3228.
   PubMed Web of Science ®Google Scholar
• Katre, N.V., et al. 1998. Multivesicular liposome (DepoFoam) technology for the sustained delivery of insulin‐like growth factor‐I (IGF‐I). Journal of Pharmaceutical Sciences, 87 (11), 1341–1346.
   PubMed Web of Science ®Google Scholar
• Kim, S., et al. 1983. Preparation of multivesicular liposomes. Biochimica et Biophysica Acta, 728 (3), 339–348.
   PubMed Web of Science ®Google Scholar
• Li, N., et al. 2019. Multivesicular liposomes for the sustained release of angiotensin I-converting enzyme (ACE) inhibitory peptides from peanuts: design, characterization, and in vitro evaluation. Molecules, 24 (9), 1746.
   PubMed Web of Science ®Google Scholar
• Liu, J., et al. 2015. Liposomes for systematic delivery of vancomycin hydrochloride to decrease nephrotoxicity: characterization and evaluation. Asian Journal of Pharmaceutical Sciences, 10 (3), 212–222.
   Web of Science ®Google Scholar
• Ma, T., et al. 2011. Nano-hydroxyapatite/chitosan/konjac glucomannan scaffolds loaded with cationic liposomal vancomycin: preparation, in vitro release and activity against Staphylococcus aureus biofilms. Journal of Biomaterials Science. Polymer Edition, 22 (12), 1669–1681.
   PubMed Web of Science ®Google Scholar
• Mantripragada, S., 2002. A lipid based depot (DepoFoam® technology) for sustained release drug delivery. Progress in Lipid Research, 41 (5), 392–406.
   PubMed Web of Science ®Google Scholar
• Masters, E.A., et al. 2019. Evolving concepts in bone infection: redefining “biofilm”,“acute vs. chronic osteomyelitis”,“the immune proteome” and “local antibiotic therapy. Bone Research, 7 (1), 20.
   PubMedGoogle Scholar
• Molavi, F., Hamishehkar, H., and Nokhodchi, A., 2020. Impact of tablet shape on drug dissolution rate through immediate released tablets. Advanced Pharmaceutical Bulletin, 10 (4), 656–661.
   PubMed Web of Science ®Google Scholar
• Mu, H., et al. 2018. Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization. Drug Delivery, 25 (1), 1372–1383.
   PubMed Web of Science ®Google Scholar
• Muppidi, K., et al. 2012. Development and stability studies of novel liposomal vancomycin formulations. Isrn Pharmaceutics, 2012, 1–8.
   Google Scholar
• Nandi, S.K., et al. 2016. Understanding osteomyelitis and its treatment through local drug delivery system. Biotechnology Advances, 34 (8), 1305–1317.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards, 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. National Committee for Clinical Laboratory Standards (NCCLS), Wayne, PA, USA.
   Google Scholar
• Paharik, A.E., and Horswill, A.R., 2016. The staphylococcal biofilm: adhesins, regulation, and host response. Virulence Mechanisms of Bacterial Pathogens, Washington, DC: ASM Press; P. 529–566.
   Google Scholar
• Persson, L., Johansson, C., and Rydén, C., 2009. Antibodies to Staphylococcus aureus bone sialoprotein-binding protein indicate infectious osteomyelitis. Clinical and Vaccine ImmunologyI, 16 (6), 949–952.
   PubMedGoogle Scholar
• Pumerantz, A., et al. 2011. Preparation of liposomal vancomycin and intracellular killing of meticillin-resistant Staphylococcus aureus (MRSA). International Journal of Antimicrobial Agents, 37 (2), 140–144.
   PubMed Web of Science ®Google Scholar
• Rajvaidya, M., et al. 2007. Development and characterization of multivesicular liposomes bearing serratiopeptidase for sustained delivery. Journal of Drug Delivery Science and Technology, 17 (5), 315–320.
   Web of Science ®Google Scholar
• Shen, Y., et al. 2011. Multivesicular liposome formulations for the sustained delivery of ropivacaine hydrochloride: preparation, characterization, and pharmacokinetics. Drug Delivery, 18 (5), 361–366.
   PubMed Web of Science ®Google Scholar
• Suchý, T., et al. 2017. The release kinetics, antiµµrobial activity and cytocompatibility of differently prepared collagen/hydroxyapatite/vancomycin layers: Microstructure vs. nanostructure. European Journal of Pharmaceutical Sciences : official Journal of the European Federation for Pharmaceutical Sciences, 100, 219–229.
   PubMed Web of Science ®Google Scholar
• Sur, S., et al. 2014. Active loading of preencapsulated drugs into stealth liposomes. Proceedings of the National Academy of Sciences of the United States of America, 111 (6), 2283–2288.
   PubMed Web of Science ®Google Scholar
• Takács-Novák, K., et al. 1993. Acid-base properties and proton-speciation of vancomycin. International Journal of Pharmaceutics, 89 (3), 261–263.
   Web of Science ®Google Scholar
• Trombetta, R.P., et al. 2019. Calcium phosphate spacers for the local delivery of sitafloxacin and rifampin to treat orthopedic infections: efficacy and proof of concept in a mouse model of single-stage revision of device-associated osteomyelitis. Pharmaceutics, 11 (2), 94.
   PubMed Web of Science ®Google Scholar
• Uda, K., et al, 2019. Ototoxicity and nephrotoxicity with elevated serum concentrations following vancomycin overdose: a retrospective case series. The Journal of Pediatric Pharmacology and Therapeutics : JPPT : The Official Journal of PPAG, 24 (5), 450–455.
   PubMedGoogle Scholar
• Vatankhah, M., et al. 2021. Preparation and optimization of Vancomycin hydrochloride encapsulated multivesicular liposomes for sustained locoregional delivery. International Pharmacy Acta, 4 (1), 4e6–1.
   Google Scholar
• Velpula, A., et al. 2013. Proliposome powders for enhanced intestinal absorption and bioavailability of raloxifene hydrochloride: effect of surface charge. Drug Development and Industrial Pharmacy, 39 (12), 1895–1906.
   PubMed Web of Science ®Google Scholar
• Volejníková, A., et al. 2019. Antimicrobial peptides prevent bacterial biofilm formation on the surface of polymethylmethacrylate bone cement. Journal of Medical Microbiology, 68 (6), 961–972.
   PubMed Web of Science ®Google Scholar
• Webb, M.S., et al. 1998. Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation. Antimicrobial Agents and Chemotherapy, 42 (1), 45–52.
   PubMed Web of Science ®Google Scholar
• Wu, P., and Grainger, D.W., 2006. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials, 27 (11), 2450–2467.
   PubMed Web of Science ®Google Scholar
• Yan, L., et al. 2015. Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres. Drug Design, Development and Therapy, 9, 3665–3676.
   PubMed Web of Science ®Google Scholar
• Zucker, D., et al. 2009. Liposome drugs’ loading efficiency: a working model based on loading conditions and drug’s physicochemical properties. Journal of Controlled Release : official Journal of the Controlled Release Society, 139 (1), 73–80.
   PubMed Web of Science ®Google Scholar
• Zuo, J., et al. 2012. Multivesicular liposomes for the sustained release of thymopentin: stability, pharmacokinetics and pharmacodynamics. Die Pharmazie-An International Journal of Pharmaceutical Sciences, 67 (6), 507–512. [Original source: https://studycrumb.com/alphabetizer]
   Google Scholar